BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38097921)

  • 1. Assessment of Bone Marrow Involvement in Extranodal NK/T-Cell Lymphoma: Positron Emission Tomography versus Bone Marrow Biopsy, and the Significance of Minimal Involvement by EBV+ Cells (KROG 18-09).
    Lee TH; Kim HJ; Lee JH; Lee J; Kim JH; Oh D; Eom KY
    Cancer Res Treat; 2024 Apr; 56(2):688-696. PubMed ID: 38097921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of bone marrow involvement in angioimmunoblastic T-cell lymphoma should be based on both [
    Liang X; Yang C; Su M; Zou L
    Curr Med Res Opin; 2024 May; 40(5):803-811. PubMed ID: 38626218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT may replace bone marrow biopsy for the evaluation of bone marrow involvement in selected mature T- and natural killer-cell lymphomas: A meta-analysis.
    Guo L; Wang R; Hou N; Kuang A; Shen G
    Eur J Radiol; 2024 Mar; 172():111353. PubMed ID: 38320330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-treatment [
    Chen J; Zhao Y
    Hematology; 2024 Dec; 29(1):2325317. PubMed ID: 38465661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extranodal NK/T-cell lymphoma with localized relapse in bone marrow of lower leg detected using PET-CT.
    Nakamura T; Tatetsu H; Higuchi Y; Endo S; Shiraishi S; Kawanaka K; Imakane D; Sonoda M; Furuta R; Shichijo T; Honda Y; Karube K; Mikami Y; Nosaka K; Matsuoka M; Yasunaga JI
    J Clin Exp Hematop; 2024; 64(1):45-51. PubMed ID: 38538318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of routine bone marrow examination in patients with extranodal NK/T-cell lymphoma staged with PET/CT.
    Yang Y; Wang JJ; Zhao RZ; Huang C; Shi GQ; Zheng H; Tang TL; Liao SQ; Chen JH; Shen JZ; Liu TB; Xu BH; Zhang YJ
    Cancer; 2022 Nov; 128(22):3943-3950. PubMed ID: 36181669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection performance and prognostic value of initial bone marrow involvement in diffuse large B-cell lymphoma: a single centre
    Doma A; Zevnik K; Studen A; Prevodnik VK; Gasljevic G; Novakovic BJ
    Radiol Oncol; 2024 Mar; 58(1):15-22. PubMed ID: 38378029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
    Zhang Y; Zhou J; Wang L; Li JY; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):885-890. PubMed ID: 33113633
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT.
    Zhou Z; Chen C; Li X; Li Z; Zhang X; Chang Y; Lu L; Cui Y; Ma Y; Zhang M
    Ann Hematol; 2015 Jun; 94(6):963-7. PubMed ID: 25547320
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Yang C; Wu W; Zhou H; Zhao S; Tian R; Xiang M; Zou L
    Front Oncol; 2022; 12():894804. PubMed ID: 35965550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET for Evaluation of Bone Marrow Status in T-Cell Lymphoma.
    Koh Y; Lee JM; Woo GU; Paeng JC; Youk J; Yoon SS; Kim I; Kang KW
    Clin Nucl Med; 2019 Jan; 44(1):4-10. PubMed ID: 30371574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate timing to perform an interim
    Wang R; Zhang Y; Fan Q; Jiang M; Zou L; Su M
    Ann Hematol; 2024 Mar; 103(3):885-892. PubMed ID: 38030892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/CT-based bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer/T-cell lymphoma.
    Wang Y; Xie L; Tian R; Deng Y; Zhang W; Zou L; Zhang H; Liu J; Zhao S; Ding W; Liu W; Jiang M
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2529-2539. PubMed ID: 31485768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.
    Chen S; Wang S; He K; Ma C; Fu H; Wang H
    Eur Radiol; 2018 Jul; 28(7):2942-2950. PubMed ID: 29383519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic and Prognostic Value of
    Chen X; Qiao WL; Song JH; Liu CC; Han L; Wu S; Zhao JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1044-1049. PubMed ID: 37551475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of bone marrow
    Lee JW; Lee SC; Kim HJ; Lee SM
    Hell J Nucl Med; 2017; 20(1):17-25. PubMed ID: 28315904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Bone Marrow F-18 FDG Uptake in Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma.
    Wang J; Kim D; Kang WJ; Cho H
    Nucl Med Mol Imaging; 2020 Feb; 54(1):28-34. PubMed ID: 32206128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of bone marrow infiltration detected by PET-CT in newly diagnosed diffuse large B cell lymphoma.
    Liang JH; Sun J; Wang L; Fan L; Chen YY; Qu XY; Li TN; Li JY; Xu W
    Oncotarget; 2016 Apr; 7(14):19072-80. PubMed ID: 26919239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma.
    Kim M; Ahn SY; Ahn JS; Song GY; Jung SH; Lee JJ; Kim HJ; Lee JH; Shin MG; Song SY; Yang DH
    J Korean Med Sci; 2022 Jan; 37(1):e2. PubMed ID: 34981678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.